Skip to main content
. 2017 Mar 10;8(16):27216–27239. doi: 10.18632/oncotarget.16111

Table 7. The percentages of alterations in CAP2, CAP1, CFL1, CFL2 and DSTN genes.

Cancer CAP1 CAP2 CFL1 CFL2 DSTN
NEPC 13% 19% 30% 21% 19%
Ovarian 11% 12% 2.9% 1.3% 2.9%
Bladder 11% 9% 2.4% 1.6% 0.8%
Bladder 10% 9% 1.6% 1.6% 0.8%
Pancrease 2.8% 4% 10% 5% 4%